News

Every 4 minutes in the U.S., a patient loses a limb due to diabetes complications  Black Americans face diabetes-related amputations 3x as often as white Americans Podimetrics strives to reduce disparities in diabetes care and unnecessary limb loss SOMERVILLE, Mass., March 24, 2022 — Podimetrics, creator of the FDA-cleared SmartMat™ and integrated clinical care services […]

In an Authority Magazine interview, Empirical Spine President & CEO Richard Treadwell discusses the education and career progression that led him to focus on healthcare breakthroughs. In the article, he shares his leadership style and tips for success in the med tech industry. In addition, he explains how the LimiFlex™ Dynamic Sagittal Tether™ (DST) will

MENLO PARK, Calif.— March 16, 2022 — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced the appointment of Brenda Becker to its Board of Directors, effective March 15, 2022. As part of her duties, Ms. Becker has joined the

SAN DIEGO, CA – MARCH 10, 2022 – Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of precision medicine in psoriasis,  has appointed Ted St. Martin as its Chief Financial Officer (CFO), effective March 7, 2022. Mr. St. Martin brings over 25 years of experience in technical accounting and

Mr. Decker has 30+ years operating and finance experience in Fortune 500, middle market and emerging growth companies as both a full-time employee and as a fractional CFO. His broad experience includes technology, software, life sciences and healthcare. He has functional expertise in financing, operations, intellectual property licensing, strategic planning, contracts, supply and demand planning,

MENLO PARK, Calif.— March 2, 2022 — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced that data from clinical studies of the OMNI® Surgical System will be presented at the 2022 American Glaucoma Society (AGS) Annual Meeting. The conference

Ms. Rice-Johnson has more than 30 years of experience in the health insurance industry and is CEO of Diversified Businesses for Highmark Inc. and chief growth officer. Her leadership has not only redefined the payer-provider relationship and yielded unparalleled financial performance, but she has also delivered innovative clinical solutions that aim to improve health outcomes. Her

SAN DIEGO, CA – March 1, 2022 – Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in psoriasis,   has appointed Deborah L. Rice-Johnson to its Board of Directors, effective February 28, 2022.  Ms. Rice-Johnson has more than 30 years of experience in the health insurance industry.

MENLO PARK, Calif.— February 17, 2022 — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform standards of care and improve patients’ lives, today announced the launch of its “Don’t Wait for Too Late” educational campaign designed to raise awareness among the optometric community of minimally invasive

Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the close of a $26 million Series B financing. The round was led by 3×5 Partners, along with new investors including Asahi Kasei Ventures, Cadence Healthcare Ventures, and existing investors Arboretum